Highlights of the second quarter include:

• Revenue of $86.6 million, an increase of 22% compared to Q2 FY19.
• Net income of $19.4 million, a decrease of 14% compared to $22.5 million in Q2 FY19.
• Net income per diluted share of $0.30 compared to $0.36 in Q2 FY19.
• Non-GAAP net income per diluted share of $0.45 compared to $0.36 in Q2 FY19.
• Adjusted EBITDA of $40.6 million, an increase of 28% compared to Q2 FY19.
• HSA Members of 4.2 million, an increase of 16% compared to Q2 FY19.
• Total Custodial Assets of $8.5 billion, an increase of 21% compared to Q2 FY19.

DRAPER, Utah, Sept. 03, 2019 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) ("HealthEquity" or the "Company"), the nation's largest health savings account ("HSA") non-bank custodian, today announced financial results for its second quarter ended July 31, 2019.

“We believe that HealthEquity’s results in the second quarter and the speedy close of the WageWorks acquisition position us for a strong second half selling season,” said Jon Kessler, HealthEquity’s President and CEO. “HealthEquity’s more than 215,000 new HSAs and $400 million in custodial asset growth in the first half provides the team the opportunity to once again outpace HSA market growth this year. HealthEquity’s unique combined offering of HSAs and consumer-directed benefits will enable us to continue building our leading HSA market position.”

Second quarter financial results

For the second quarter ended July 31, 2019, HealthEquity reported revenue of $86.6 million, an increase of 22% compared to $71.1 million for the second quarter ended July 31, 2018. Revenue consisted of:

• Service revenue of $26.3 million, an increase of 5% compared to Q2 FY19.
• Custodial revenue of $43.6 million, an increase of 42% compared to Q2 FY19.
• Interchange revenue of $16.7 million, an increase of 8% compared to Q2 FY19.

Net income was $19.4 million for the second quarter ended July 31, 2019, compared to $22.5 million for the second quarter ended July 31, 2018.

Net income per diluted share was $0.30 for the second quarter ended July 31, 2019, compared to $0.36 for the second quarter ended July 31, 2018.

Non-GAAP net income per diluted share was $0.45 for the second quarter ended July 31, 2019, compared to $0.36 for the second quarter ended July 31, 2018.

Adjusted EBITDA was $40.6 million for the second quarter ended July 31, 2019, an increase of 28% compared to $31.8 million for the second quarter ended July 31, 2018. Adjusted EBITDA was 47% of revenue for the second quarter ended July 31, 2019, compared to 45% for the second quarter ended July 31, 2018.

As of July 31, 2019, we had $815.2 million of cash and cash equivalents and no outstanding debt. This compares to $361.5 million in cash and cash equivalents and no outstanding debt as of January 31, 2019.

HSA Member and Custodial Asset metrics

The total number of HSAs for which we serve as a non-bank custodian ("HSA Members") as of July 31, 2019 was 4.2 million, an increase of 16% from 3.6 million as of July 31, 2018. Total Active HSA Members as of July 31, 2019 was 3.3 million, an increase of 13% from 2.9 million as of July 31, 2018. Total HSA Members with investments as of July 31, 2019 was 187,000, an increase of 31% from 143,000 as of July 31, 2018.

Total Custodial Assets as of July 31, 2019 was $8.5 billion, an increase of 21% year over year, consisting of:

• Custodial Cash Assets of $6.5 billion, an increase of 17% compared to July 31, 2018; and
• Custodial Investment Assets of $2.1 billion, an increase of 38% compared to July 31, 2018.

Business outlook

We have updated the HealthEquity standalone outlook for the year ending January 31, 2020. We expect our revenue to be between $341 million and $347 million. Our outlook for net income is a range of $9 million to $13 million, resulting in a net income per diluted share range of $0.13 to $0.19. Our Adjusted EBITDA outlook is a range of $138 million to $142 million. We define Adjusted EBITDA as adjusted earnings before interest, taxes, depreciation and amortization, amortization of acquired intangible assets, stock-based compensation expense, integration and acquisition-related costs, unrealized gains and losses on marketable equity securities, and other certain non-operating items. We also expect our non-GAAP net income to be in a range between $76 million and $80 million. Our non-GAAP net income is calculated by adding back to net income amortization of acquired intangible assets, stock-based compensation expense, and integration and acquisition-related costs, net of an estimated statutory tax rate of 24%, subtracting the excess tax benefits due to the adoption of Accounting Standards Update ("ASU") 2016-09, and adjusting for unrealized gains and losses on marketable equity securities, net of an estimated statutory tax rate of 24%. Our non-GAAP net income outlook results in a non-GAAP net income per diluted share range between $1.10 to $1.16 (based on an estimated 69 million weighted-average shares outstanding).

Regarding the WageWorks acquisition, which closed August 30, 2019, we will include WageWorks' operating results for the five months from September through January 2020. In addition to our outlook for the HealthEquity standalone business above, we expect WageWorks revenue for the five months to be between $170 and $175 million.

A reconciliation of the non-GAAP financial measures used in this release to the most comparable GAAP financial measures is included with the financial tables at the end of this release.

Conference call

HealthEquity management will host a conference call at 5:00 pm (Eastern Time) on Tuesday, September 3, 2019 to discuss the fiscal second quarter 2020 financial results. The conference call will be accessible by dialing 844-791-6252, or 661-378-9636 for international callers, and referencing conference ID 5799847. A live audio webcast of the call will also be available on the investor relations section of our website at http://ir.healthequity.com.

Non-GAAP financial Information

To supplement our financial information presented on a GAAP basis, we disclose non-GAAP financial measures, including Adjusted EBITDA, non-GAAP net income, and non-GAAP net income per diluted share.

• Adjusted EBITDA is adjusted earnings before interest, taxes, depreciation and amortization, amortization of acquired intangible assets, stock-based compensation expense, integration and acquisition-related costs, unrealized gains and losses on marketable equity securities, and other certain non-operating items.
• Non-GAAP net income is calculated by adding back to GAAP net income amortization of acquired intangible assets, stock-based compensation expense, and integration and acquisition-related costs, net of an estimated statutory tax rate, subtracting the excess tax benefits due to the adoption of ASU 2016-09, and adjusting for unrealized gains and losses on marketable equity securities, net of an estimated statutory tax rate.
• Non-GAAP net income per diluted share is calculated by dividing non-GAAP net income by diluted weighted-average shares outstanding.

Non-GAAP financial measures should be considered in addition to results prepared in accordance with GAAP and should not be considered as a substitute for, or superior to, GAAP results. We believe that these non-GAAP financial measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to the Company's financial condition and results of operations. The Company cautions investors that non-GAAP financial information, by its nature, departs from GAAP; accordingly, its use can make it difficult to compare current results with results from other reporting periods and with the results of other companies. Whenever we use these non-GAAP financial measures, we provide a reconciliation of the applicable non-GAAP financial measure to the most closely applicable GAAP financial measure. Investors are encouraged to review the related GAAP financial measures and the reconciliation of the non-GAAP financial measures to their most directly comparable GAAP financial measure as detailed in the tables below.

About HealthEquity

HealthEquity administers Health Savings Accounts (HSAs) and other consumer directed benefits for nearly 12 million members in partnership with employers, benefits advisors and health and retirement plan providers who share our mission to connect health and wealth and value our culture of remarkable “Purple” service. For more information, visit www.healthequity.com.

Forward-looking statements

This press release contains “forward-looking statements" within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to, statements regarding our industry, business strategy, plans, goals and expectations concerning our markets and market position, product expansion, future operations, expenses and other results of operations, revenue, margins, profitability, future efficiencies, tax rates, capital expenditures, liquidity and capital resources and other financial and operating information. When used in this discussion, the words “may,” “believes,” “intends,” “seeks,” “anticipates,” “plans,” “estimates,” “expects,” “should,” “assumes,” “continues,” “could,” “will,” “future” and the negative of these or similar terms and phrases are intended to identify forward-looking statements in this press release.

Forward-looking statements reflect our current expectations regarding future events, results or outcomes. These expectations may or may not be realized. Although we believe the expectations reflected in the forward-looking statements are reasonable, we can give you no assurance these expectations will prove to be correct. Some of these expectations may be based upon assumptions, data or judgments that prove to be incorrect. Actual events, results and outcomes may differ materially from our expectations due to a variety of known and unknown risks, uncertainties and other factors. Although it is not possible to identify all of these risks and factors, they include, among others, risks related to the following:

• our ability to realize the anticipated financial and other benefits from combining the operations of WageWorks with our business in an efficient and effective manner;
• our ability to compete effectively in a rapidly evolving healthcare industry;
• our dependence on the continued availability and benefits of tax-advantaged health savings accounts;
• our ability to successfully identify, acquire and integrate additional portfolio purchases or acquisition targets;
• the significant competition we face and may face in the future, including from those with greater resources than us;
• our reliance on the availability and performance of our technology and communications systems;
• recent and potential future cybersecurity breaches of our technology and communications systems and other data interruptions, including resulting costs and liabilities, reputational damage and loss of business;
• the current uncertain healthcare environment, including changes in healthcare programs and expenditures and related regulations;
• our ability to comply with current and future privacy, healthcare, tax, investment advisor and other laws applicable to our business;
• our reliance on partners and third party vendors for distribution and important services;
• our ability to develop and implement updated features for our technology and communications systems and successfully manage our growth;
• our ability to protect our brand and other intellectual property rights; and
• our reliance on our management team and key team members.

For a detailed discussion of these and other risk factors, please refer to the risks detailed in our filings with the Securities and Exchange Commission, including, without limitation, our most recent Annual Report on Form 10-K and subsequent periodic and current reports. Past performance is not necessarily indicative of future results. We undertake no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release.

Investor Relations ContactRichard Putnam801-727-1209[email protected]

HealthEquity, Inc. and its subsidiariesCondensed consolidated balance sheets
(in thousands, except par value)	July 31, 2019				January 31, 2019
	(unaudited)
Assets
Current assets
Cash and cash equivalents	$	815,160			$	361,475
Accounts receivable, net of allowance for doubtful accounts as of July 31, 2019 and January 31, 2019 of $105 and $125, respectively	27,357				25,668
Other current assets	10,999				7,534
Total current assets	853,516				394,677
Other investments	81,839				709
Property and equipment, net	9,873				8,223
Operating lease right-of-use assets	36,716				—
Intangible assets, net	88,768				79,666
Goodwill	4,651				4,651
Deferred tax asset	666				1,677
Other assets	22,311				20,413
Total assets	$	1,098,340			$	510,016
Liabilities and stockholders’ equity
Current liabilities
Accounts payable	$	2,740			$	3,520
Accrued compensation	11,055				16,981
Accrued liabilities	19,392				8,552
Operating lease liabilities	3,954				—
Total current liabilities	37,141				29,053
Operating lease liabilities, non-current	35,660				—
Deferred tax liability	7,773				916
Other long-term liabilities	735				2,968
Total liabilities	81,309				32,937
Commitments and contingencies
Stockholders’ equity
Preferred stock, $0.0001 par value, 100,000 shares authorized, no shares issued and outstanding as of July 31, 2019 and January 31, 2019, respectively	—				—
Common stock, $0.0001 par value, 900,000 shares authorized, 70,603 and 62,446 shares issued and outstanding as of July 31, 2019 and January 31, 2019, respectively	7				6
Additional paid-in capital	783,986				305,223
Accumulated earnings	233,038				171,850
Total stockholders’ equity	1,017,031				477,079
Total liabilities and stockholders’ equity	$	1,098,340			$	510,016

HealthEquity, Inc. and its subsidiariesCondensed consolidated statements of operations and comprehensive income (unaudited)
(in thousands, except per share data)	Three months ended July 31,								Six months ended July 31,
		2019				2018				2019				2018
Revenue:
Service revenue	$	26,282			$	24,935			$	53,090			$	49,756
Custodial revenue	43,614				30,715				85,566				59,149
Interchange revenue	16,727				15,417				35,019				32,066
Total revenue	86,623				71,067				173,675				140,971
Cost of revenue:
Service costs	19,745				17,199				40,394				35,246
Custodial costs	4,209				3,502				8,332				6,941
Interchange costs	4,229				3,791				8,756				7,853
Total cost of revenue	28,183				24,492				57,482				50,040
Gross profit	58,440				46,575				116,193				90,931
Operating expenses:
Sales and marketing	8,391				7,243				17,361				14,103
Technology and development	11,645				8,398				22,550				16,377
General and administrative	9,262				7,893				17,971				15,400
Integration	2,784				—				2,784				—
Amortization of acquired intangible assets	1,494				1,478				2,985				2,948
Total operating expenses	33,576				25,012				63,651				48,828
Income from operations	24,864				21,563				52,542				42,103
Other income (expense), net	(1,128		)		(75		)		22,472				(76		)
Income before income taxes	23,736				21,488				75,014				42,027
Income tax provision (benefit)	4,370				(1,029		)		13,826				(3,067		)
Net income and comprehensive income	$	19,366			$	22,517			$	61,188			$	45,094
Net income per share:
Basic	$	0.30			$	0.36			$	0.97			$	0.73
Diluted	$	0.30			$	0.36			$	0.94			$	0.72
Weighted-average number of shares used in computing net income per share:
Basic	64,220				61,880				63,289				61,531
Diluted	65,583				63,397				64,785				63,060

HealthEquity, Inc. and its subsidiariesCondensed consolidated statements of cash flows (unaudited)
	Six months ended July 31,
(in thousands)		2019				2018
Cash flows from operating activities:
Net income	$	61,188			$	45,094
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	9,722				8,916
Unrealized (gains) losses on marketable equity securities and other	(27,180		)		86
Deferred taxes	7,868				2,351
Stock-based compensation	13,618				9,727
Changes in operating assets and liabilities:
Accounts receivable	(1,689		)		(3,304		)
Other assets	(5,036		)		(6,921		)
Operating lease right-of-use assets	1,286				—
Accounts payable	(1,083		)		(837		)
Accrued compensation	(5,926		)		(2,826		)
Accrued liabilities and other current liabilities	4,942				56
Operating lease liabilities, non-current	(1,210		)		—
Other long-term liabilities	331				298
Net cash provided by operating activities	56,831				52,640
Cash flows from investing activities:
Purchases of intangible member assets	(1,736		)		(1,014		)
Purchases of marketable equity securities and other	(53,845		)		(368		)
Purchases of property and equipment	(3,492		)		(2,690		)
Purchases of software and capitalized software development costs	(9,518		)		(4,701		)
Net cash used in investing activities	(68,591		)		(8,773		)
Cash flows from financing activities:
Proceeds from follow-on equity offering, net of payments for offering costs	458,881				—
Proceeds from exercise of common stock options	6,564				18,469
Net cash provided by financing activities	465,445				18,469
Increase in cash and cash equivalents	453,685				62,336
Beginning cash and cash equivalents	361,475				199,472
Ending cash and cash equivalents	$	815,160			$	261,808
Supplemental cash flow data:
Interest expense paid in cash	$	101			$	101
Income taxes paid in cash, net of refunds received	9,119				554
Supplemental disclosures of non-cash investing and financing activities:
Purchases of property and equipment included in accounts payable or accrued liabilities at period end	$	3			$	14
Purchases of software and capitalized software development costs included in accounts payable or accrued liabilities at period end	487				175
Purchases of intangible member assets accrued during the period	6,500				181
Exercise of common stock options receivable	87				135
Follow-on equity offering costs accrued during the period	386				—
Debt issuance costs accrued during the period	345				—

Stock-based compensation expense (unaudited)

Total stock-based compensation expense included in the consolidated statements of operations and comprehensive income is as follows:

		Three months ended July 31,								Six months ended July 31,
(in thousands)			2019				2018				2019				2018
Cost of revenue		$	1,010			$	807			$	1,869			$	1,220
Sales and marketing		1,158				891				2,166				1,596
Technology and development		1,930				1,300				3,429				2,291
General and administrative		3,492				2,490				6,154				4,620
Total stock-based compensation expense		$	7,590			$	5,488			$	13,618			$	9,727

HSA Members (unaudited)

(in thousands, except percentages)			July 31, 2019				July 31, 2018				% Change				January 31, 2019
HSA Members			4,163				3,574				16	%			3,994
Average HSA Members - Year-to-date			4,073				3,488				17	%			3,608
Average HSA Members - Quarter-to-date			4,119				3,533				17	%			3,813
New HSA Members - Year-to-date			215				219				(2	)%			679
New HSA Members - Quarter-to-date			126				121				4	%			341
Active HSA Members			3,300				2,933				13	%			3,241
HSA Members with investments			187				143				31	%			163

HSA Member Custodial assets (unaudited)

(in millions, except percentages)		July 31, 2019				July 31, 2018					% Change			January 31, 2019
Custodial cash		$	6,460			$	5,537				17	%		$	6,428
Custodial investments		2,056				1,494					38	%		1,670
Total custodial assets		$	8,516			$	7,031				21	%		$	8,098
Average daily custodial cash - Year-to-date		$	6,404			$	5,478				17	%		$	5,586
Average daily custodial cash - Quarter-to-date		$	6,402			$	5,489				17	%		$	5,837

Net income reconciliation to Adjusted EBITDA (unaudited)

		Three months ended July 31,								Six months ended July 31,
(in thousands)			2019				2018				2019				2018
Net income		$	19,366			$	22,517			$	61,188			$	45,094
Interest income		(1,884		)		(303		)		(3,227		)		(561		)
Interest expense		67				69				130				136
Income tax provision (benefit)		4,370				(1,029		)		13,826				(3,067		)
Depreciation and amortization		3,455				2,918				6,737				5,968
Amortization of acquired intangible assets		1,494				1,478				2,985				2,948
Stock-based compensation expense		7,590				5,488				13,618				9,727
Integration-related costs		2,784				—				2,784				—
Acquisition-related costs		6,596				224				7,780				225
Unrealized gain on marketable equity securities		(3,774		)		—				(27,285		)		—
Other (1)		579				439				1,030				958
Adjusted EBITDA		$	40,643			$	31,801			$	79,566			$	61,428

(1) For the three months ended July 31, 2019 and 2018, Other consisted of non-income-based taxes of $108 and $116, other (income)/costs of $15 and $(32), and amortization of incremental costs to obtain a contract of $456 and $355, respectively. For the six months ended July 31, 2019 and 2018, Other consisted of non-income-based taxes of $121 and $220, other costs of $9 and $56, and amortization of incremental costs to obtain a contract of $900 and $682, respectively.

Reconciliation of net income outlook to Adjusted EBITDA outlook (unaudited)

	Outlook for the year ending
(in millions)	January 31, 2020
Net income	$9 - $13
Interest expense	~ 23
Income tax benefit	~ (1)
Depreciation and amortization	~ 16
Amortization of acquired intangible assets	~ 36
Stock-based compensation expense	~ 28
Integration-related costs	~ 29
Acquisition-related costs	~ 27
Unrealized gain on marketable equity securities	~ (28)
Other	~ (1)
Adjusted EBITDA	$138 - $142

Reconciliation of non-GAAP net income per diluted share (unaudited)

	Three months ended						Six months ended						Outlook for theyear ending
(in millions, except per share data)	July 31, 2019			July 31, 2018			July 31, 2019			July 31, 2018			January 31, 2020
Net income	$19			$22			$61			$45			$9 - $13
Amortization of acquired intangible assets, net of tax (1)		1			1			3			3		27
Stock-based compensation, net of tax (1)		6			4			10			7		22
Excess tax benefit due to adoption of ASU 2016-09		(1	)		(5	)		(3	)		(12	)	(3	)
Integration-related costs, net of tax (1)		2			-			2			-		22
Acquisition-related costs, net of tax (1)		5			-			6			-		20
Unrealized gain on marketable equity securities, net of tax (1)		(3	)		-			(21	)		-		(21	)
Non-GAAP net income	$29			$22			$58			$43			$76 - $80
Diluted weighted-average shares used in computing GAAP and Non-GAAP per share amounts		66			63			65			63		69
Non-GAAP net income per diluted share (2)	$0.45			$0.36			$0.89			$0.68			$1.10 - $1.16

(1) For the three and six months ended July 31, 2019 and 2018, the Company used an estimated statutory tax rate of 24% to calculate the net impact of stock-based compensation expense, mark-to-market adjustments, and acquisition and integration-related costs.

(2) Non-GAAP net income per diluted share does not calculate due to rounding of non-GAAP net income and diluted weighted-average shares.

Certain terms

Term		Definition
HSA		A financial account through which consumers spend and save long-term for healthcare on a tax-advantaged basis.
HSA Member		An HSA for which we serve as custodian.
Active HSA Member		An HSA Member that (i) is associated with a Health Plan and Administrator Partner or an Employer Partner, in each case as of the end of the applicable period; or (ii) has held a custodial balance at any point during the previous twelve month period.
Custodial cash assets		HSA Members' deposits with our federally-insured custodial depository partners and custodial cash deposits invested in an annuity contract with our insurance company partner.
Custodial investments		HSA Members' investments in mutual funds through our custodial investment fund partner.
Employer Partner		Our employer clients.
Health Plan and Administrator Partner		Our Health Plan and Administrator clients.
Adjusted EBITDA		Adjusted earnings before interest, taxes, depreciation and amortization, amortization of acquired intangible assets, stock-based compensation expense, unrealized gains and losses on marketable equity securities, acquisition and integration-related costs, and other certain non-operating items.
Non-GAAP net income		Calculated by adding back to net income amortization of acquired intangible assets, stock-based compensation expense, and integration and acquisition-related costs, net of an estimated statutory tax rate, subtracting the excess tax benefits due to the adoption of ASU 2016-09, and adjusting for unrealized gains and losses on marketable equity securities, net of an estimated statutory tax rate.
Non-GAAP net income per diluted share		Calculated by dividing non-GAAP net income by diluted weighted-average shares outstanding.

Source: HealthEquity, Inc.

Globe Newswire Press Releases

HealthEquity (HQY) Tops Q2 EPS by 10c, Offers FY GuidanceSeptember 3, 2019 4:06 PM